These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26985652)

  • 21. Modification of curcumin with polyethylene glycol enhances the delivery of curcumin in preadipocytes and its antiadipogenic property.
    Kim CY; Bordenave N; Ferruzzi MG; Safavy A; Kim KH
    J Agric Food Chem; 2011 Feb; 59(3):1012-9. PubMed ID: 21204534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in β-Diketocyclisation of Curcumin Derivatives and their Antitumor Activity.
    Dai H; Zhang S; Zheng X; Luo Z; Chen H; Yao X
    Chem Biodivers; 2024 Feb; 21(2):e202301556. PubMed ID: 38095134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin: the Indian solid gold.
    Aggarwal BB; Sundaram C; Malani N; Ichikawa H
    Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin and Its Potential Impact on Microbiota.
    Jabczyk M; Nowak J; Hudzik B; Zubelewicz-Szkodzińska B
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34200819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin, a component of turmeric: from farm to pharmacy.
    Gupta SC; Kismali G; Aggarwal BB
    Biofactors; 2013; 39(1):2-13. PubMed ID: 23339055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Applications of Curcumin in Diabetes: A Review and Perspective.
    Quispe C; Herrera-Bravo J; Javed Z; Khan K; Raza S; Gulsunoglu-Konuskan Z; Daştan SD; Sytar O; Martorell M; Sharifi-Rad J; Calina D
    Biomed Res Int; 2022; 2022():1375892. PubMed ID: 35155670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural Interactions of Curcumin Biotransformed Molecules with the N-Terminal Residues of Cytotoxic-Associated Gene A Protein Provide Insights into Suppression of Oncogenic Activities.
    Srivastava AK; Singh D; Roy BK
    Interdiscip Sci; 2017 Mar; 9(1):116-129. PubMed ID: 26798036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability enhancement of curcumin by complexation with phosphatidyl choline.
    Gupta NK; Dixit VK
    J Pharm Sci; 2011 May; 100(5):1987-95. PubMed ID: 21374628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine.
    Ireson CR; Jones DJ; Orr S; Coughtrie MW; Boocock DJ; Williams ML; Farmer PB; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):105-11. PubMed ID: 11815407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugate.
    Manju S; Sreenivasan K
    J Pharm Sci; 2011 Feb; 100(2):504-11. PubMed ID: 20848656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
    Mohanty C; Sahoo SK
    Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions.
    Zou L; Liu W; Liu C; Xiao H; McClements DJ
    J Agric Food Chem; 2015 Feb; 63(7):2052-62. PubMed ID: 25639191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eliminating the heart from the curcumin molecule: monocarbonyl curcumin mimics (MACs).
    Shetty D; Kim YJ; Shim H; Snyder JP
    Molecules; 2014 Dec; 20(1):249-92. PubMed ID: 25547726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of the absorption mechanism of solubilized curcumin using Caco-2 cell monolayers.
    Yu H; Huang Q
    J Agric Food Chem; 2011 Sep; 59(17):9120-6. PubMed ID: 21805974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancer.
    Heger M; van Golen RF; Broekgaarden M; Michel MC
    Pharmacol Rev; 2014; 66(1):222-307. PubMed ID: 24368738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Jun N-terminal kinase-dependent apoptotic photocytotoxicity of solvent exchange-prepared curcumin nanoparticles.
    Paunovic V; Ristic B; Markovic Z; Todorovic-Markovic B; Kosic M; Prekodravac J; Kravic-Stevovic T; Martinovic T; Micusik M; Spitalsky Z; Trajkovic V; Harhaji-Trajkovic L
    Biomed Microdevices; 2016 Apr; 18(2):37. PubMed ID: 27106025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII.
    Tønnesen HH
    Pharmazie; 2002 Dec; 57(12):820-4. PubMed ID: 12561244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability.
    Wu X; Xu J; Huang X; Wen C
    Drug Dev Ind Pharm; 2011 Jan; 37(1):15-23. PubMed ID: 20738181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel solubility-enhanced curcumin formulation showing stability and maintenance of anticancer activity.
    Zhang F; Koh GY; Jeansonne DP; Hollingsworth J; Russo PS; Vicente G; Stout RW; Liu Z
    J Pharm Sci; 2011 Jul; 100(7):2778-89. PubMed ID: 21312196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One Molecule, Many Targets and Numerous Effects: The Pleiotropy of Curcumin Lies in its Chemical Structure.
    Hatamipour M; Johnston TP; Sahebkar A
    Curr Pharm Des; 2018; 24(19):2129-2136. PubMed ID: 29788873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.